Chugai Pharmaceutical Co Ltd (CHGCY)
16.62
+0.16
(+0.97%)
USD |
OTCM |
May 03, 16:00
Chugai Pharmaceutical Market Cap: 54.69B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 54.69B |
| May 02, 2024 | 54.17B |
| May 01, 2024 | 52.22B |
| April 30, 2024 | 52.13B |
| April 29, 2024 | 51.50B |
| April 26, 2024 | 50.61B |
| April 25, 2024 | 51.30B |
| April 24, 2024 | 52.75B |
| April 23, 2024 | 55.25B |
| April 22, 2024 | 54.76B |
| April 19, 2024 | 52.29B |
| April 18, 2024 | 53.57B |
| April 17, 2024 | 53.80B |
| April 16, 2024 | 54.59B |
| April 15, 2024 | 53.61B |
| April 12, 2024 | 54.50B |
| April 11, 2024 | 56.29B |
| April 10, 2024 | 55.75B |
| April 09, 2024 | 58.28B |
| April 08, 2024 | 58.31B |
| April 05, 2024 | 59.20B |
| April 04, 2024 | 59.73B |
| April 03, 2024 | 60.71B |
| April 02, 2024 | 59.96B |
| April 01, 2024 | 61.80B |
| Date | Value |
|---|---|
| March 28, 2024 | 62.95B |
| March 27, 2024 | 64.35B |
| March 26, 2024 | 64.50B |
| March 25, 2024 | 63.57B |
| March 22, 2024 | 63.54B |
| March 21, 2024 | 64.17B |
| March 20, 2024 | 66.54B |
| March 19, 2024 | 66.40B |
| March 18, 2024 | 67.59B |
| March 15, 2024 | 66.31B |
| March 14, 2024 | 67.33B |
| March 13, 2024 | 69.10B |
| March 12, 2024 | 71.83B |
| March 11, 2024 | 72.30B |
| March 08, 2024 | 72.20B |
| March 07, 2024 | 71.18B |
| March 06, 2024 | 70.65B |
| March 05, 2024 | 68.71B |
| March 04, 2024 | 68.45B |
| March 01, 2024 | 67.19B |
| February 29, 2024 | 65.55B |
| February 28, 2024 | 64.99B |
| February 27, 2024 | 65.48B |
| February 26, 2024 | 65.48B |
| February 23, 2024 | 62.26B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
34.44B
Minimum
May 13 2019
92.96B
Maximum
Jan 12 2021
55.44B
Average
53.56B
Median
Dec 22 2021
Market Cap Benchmarks
| Takeda Pharmaceutical Co Ltd | 41.95B |
| Nxera Pharma Co Ltd | 854.21M |
| PeptiDream Inc | 1.699B |
| Stemcell Holdings Inc | 1.643M |
| Healios KK | 89.49M |
Market Cap Related Metrics
| PE Ratio | 24.18 |
| PS Ratio | 7.612 |
| Price to Book Value | 5.041 |
| Price to Free Cash Flow | 24.56 |
| Price | 16.62 |
| Earnings Yield | 4.14% |
| Operating PE Ratio | 17.90 |
| Normalized PE Ratio | 24.18 |